NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease

Go back to NeuroSense Granted U.S. Patent for Treatment of Alzheimer's Disease
(NASDAQ: NRSN) Delayed: 4.03 +0.10 (2.54%)
Previous Close $3.93    52 Week High $ 
Open $4.06    52 Week Low $ 
Day High $4.54    P/E N/A 
Day Low $3.96    EPS $ 
Volume 12,245       

(NASDAQ: NRSNW) Delayed: 0.04 --0 (-0%)
Previous Close $0.04    52 Week High $ 
Open $0.06    52 Week Low $ 
Day High $0.06    P/E N/A 
Day Low $0.04    EPS $ 
Volume 7,843